DK0398024T3 - Tumor localization and / or tumor therapy conjugates - Google Patents

Tumor localization and / or tumor therapy conjugates

Info

Publication number
DK0398024T3
DK0398024T3 DK90107187.8T DK90107187T DK0398024T3 DK 0398024 T3 DK0398024 T3 DK 0398024T3 DK 90107187 T DK90107187 T DK 90107187T DK 0398024 T3 DK0398024 T3 DK 0398024T3
Authority
DK
Denmark
Prior art keywords
polyalcohol
tumor
derivatised
protein
conjugates
Prior art date
Application number
DK90107187.8T
Other languages
Danish (da)
Inventor
Wolfgang Dr Maier-Borst
Hansjoerg Dr Sinn
Hans-Hermann Schrenk
Eckhard Dr Friedrich
Georgi Dr Graschew
Dieter Prof Dr Woehrle
Original Assignee
Deutsches Krebsforsch
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Deutsches Krebsforsch filed Critical Deutsches Krebsforsch
Application granted granted Critical
Publication of DK0398024T3 publication Critical patent/DK0398024T3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/0002—General or multifunctional contrast agents, e.g. chelated agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/65—Peptidic linkers, binders or spacers, e.g. peptidic enzyme-labile linkers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
    • A61K47/6889—Conjugates wherein the antibody being the modifying agent and wherein the linker, binder or spacer confers particular properties to the conjugates, e.g. peptidic enzyme-labile linkers or acid-labile linkers, providing for an acid-labile immuno conjugate wherein the drug may be released from its antibody conjugated part in an acidic, e.g. tumoural or environment
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/081—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins the protein being an albumin, e.g. human serum albumin [HSA], bovine serum albumin [BSA], ovalbumin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/088—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins conjugates with carriers being peptides, polyamino acids or proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Analysing Materials By The Use Of Radiation (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Apparatus For Radiation Diagnosis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Radiation-Therapy Devices (AREA)

Abstract

The invention relates to conjugates consisting of a) at least one polyalcohol or a derivatised polyalcohol, b) at least one active agent, c) at least one linker and d) a protein, characterised in that the polyalcohol(s) or the derivatised polyalcohol(s) are polyalcohols or derivatised polyalcohols which are not recognised as foreign by the defence system of an organism, and the protein is a protein which is not recognised as foreign by the defence system of an organism and can be taken up specifically or non-specifically by the tumour. These conjugates are suitable, on the one hand, for making possible a very sensitive nuclear medical diagnosis of tumours and, on the other hand, for example for making available new tumour diagnosis methods in X-ray diagnosis, computed tomography, MR imaging, electron spin resonance spectroscopy or electron microscopy. <IMAGE>
DK90107187.8T 1989-04-19 1990-03-14 Tumor localization and / or tumor therapy conjugates DK0398024T3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3912792A DE3912792A1 (en) 1989-04-19 1989-04-19 CONJUGATES FOR TUMOR LOCALIZATION AND / OR TUMOR THERAPY, METHOD FOR THE PRODUCTION THEREOF AND THEIR CONTAINING DIAGNOSTICS AND / OR THERAPEUTICS

Publications (1)

Publication Number Publication Date
DK0398024T3 true DK0398024T3 (en) 1993-03-29

Family

ID=6378961

Family Applications (1)

Application Number Title Priority Date Filing Date
DK90107187.8T DK0398024T3 (en) 1989-04-19 1990-03-14 Tumor localization and / or tumor therapy conjugates

Country Status (7)

Country Link
EP (1) EP0398024B1 (en)
JP (1) JPH0819156B2 (en)
AT (1) ATE85894T1 (en)
DE (2) DE3912792A1 (en)
DK (1) DK0398024T3 (en)
ES (1) ES2054137T3 (en)
GR (1) GR3007136T3 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4334317A1 (en) * 1993-10-08 1995-04-13 Dombaj Gmbh Apparatus for separating liquid streams containing dissociated substances
DE4435087A1 (en) * 1994-09-30 1996-04-04 Deutsches Krebsforsch Conjugate for the treatment of infectious, autoimmune and skin diseases
GB0609370D0 (en) * 2006-05-11 2006-06-21 Mock Graham A Process for cross-linking macromolecules
JP2010054305A (en) * 2008-08-27 2010-03-11 Tohoku Denshi Sangyo Kk Method for acquiring data used for cancer contraction verification

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4466951A (en) * 1982-11-12 1984-08-21 University Of California Intracellular trapping of therapeutics or tracer agents

Also Published As

Publication number Publication date
EP0398024A1 (en) 1990-11-22
ES2054137T3 (en) 1994-08-01
ATE85894T1 (en) 1993-03-15
JPH0334999A (en) 1991-02-14
EP0398024B1 (en) 1993-02-24
JPH0819156B2 (en) 1996-02-28
DE59000908D1 (en) 1993-04-01
DE3912792A1 (en) 1990-10-25
GR3007136T3 (en) 1993-07-30

Similar Documents

Publication Publication Date Title
Cherry Multimodality in vivo imaging systems: twice the power or double the trouble?
US7759625B2 (en) Systems and methods for multimodal imaging using a volumetric representation of an object
US20150208994A1 (en) Ct/mri integrated system for the diagnosis of acute strokes and methods thereof
Morris et al. Diagnostic imaging
Umutlu et al. Whole-body [18F]-FDG-PET/MRI for oncology: a consensus recommendation
Lois et al. Effect of MR contrast agents on quantitative accuracy of PET in combined whole-body PET/MR imaging
DE102005053994A1 (en) Diagnostic device for combined and / or combinable radiographic and nuclear medicine examinations and corresponding diagnostic method
Youn et al. In vivo non invasive molecular imaging for immune cell tracking in small animals
US6603991B1 (en) Method and apparatus for dual mode medical imaging system
Mandija et al. Brain and head-and-neck MRI in immobilization mask: a practical solution for MR-only radiotherapy
Jackson et al. The development of a system for transillumination computed tomography
Tang et al. Imaging radiation-induced gastrointestinal, bone marrow injury and recovery kinetics using 18F-FDG PET
DE59000908D1 (en) CONJUGATES FOR TUMOR LOCALIZATION AND / OR TUMOR THERAPY.
Shi et al. Evolution from medical imaging to visualized medicine
Keservani et al. Nanobiomaterials involved in medical imaging technologies
KR101126047B1 (en) Rf shield box for pet apparatus with pet - mri system
Iftimia et al. Advances in Optical Imaging for Clinical Medicine
Brooks et al. Studies on regional cerebral pH in patients with cerebral tumours using continuous inhalation of 11CO2 and positron emission tomography
US5250284A (en) Method for increasing nuclear magnetic resonance signals in living biological tissue using zinc
Kawata et al. Clinical impact of “true whole-body” 18F-FDG PET/CT: lesion frequency and added benefit in distal lower extremities
Richter et al. Imaging and Adenoviral gene therapy
Haegele et al. Visualization of instruments for cardiovascular intervention using MPI
Wang et al. High-resolution dynamic imaging and quantitative analysis of lung cancer xenografts in nude mice using clinical PET/CT
Somvanshi et al. Introduction to imaging modalities
Sharma et al. Study of image qualities from 6D robot–based CBCT imaging system of small animal irradiator